Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferric pyrophosphate + vitamin C is a combination nutritional supplement used for the treatment and prevention of iron deficiency anemia. Ferric pyrophosphate serves as the iron source, while vitamin C (ascorbic acid) acts as an absorption enhancer by reducing ferric iron (Fe3+) to the more soluble and readily absorbed ferrous form (Fe2+) within the gastrointestinal tract. A notable formulation of this combination is sucrosomial ferric pyrophosphate, which utilizes a phospholipid bilayer (sucrosome) to encapsulate the iron, protecting it from the acidic gastric environment and reducing common side effects like metallic taste and gastrointestinal irritation. This combination is frequently used to optimize hemoglobin levels in patients with chronic kidney disease, inflammatory bowel disease, and those undergoing major orthopedic surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric pyrophosphate + ascorbic acid.